KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer
Dingheng Lu(Union Hospital), Yifei Xing(Union Hospital), Yunxue Li(Union Hospital), Ying Yu(Fudan University), Yarong Song(Union Hospital), Liang Chen(Pingjin Hospital), Bing Liu(Central South University), Pu Zhang(Union Hospital), Decai Wang(Union Hospital), Fang Lv(Liaoning Normal University), Lulin Cheng(Union Hospital), Xuexiang Li(Northwestern Polytechnical University)
Cited by 50
Related Papers
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
|Genome Biology|2015|429
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415
Luteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studies
|Journal of Nanoparticle Research|2014|128
CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2022|115